Cortistatin protects against inflammatory airway diseases through curbing CCL2 and antagonizing NF-κB signaling pathway

Cheng Qiu,Jiayi Li,Dan Luo,Xiaomin Chen,Ruize Qu,Tianyi Liu,Feng Li,Yansong Liu
DOI: https://doi.org/10.1016/j.bbrc.2020.07.088
IF: 3.1
2020-10-01
Biochemical and Biophysical Research Communications
Abstract:<p>Asthma is a chronic inflammatory disease affecting millions of people around the world, yet much remains unknown about its underlying mechanisms. Cortistatin (CST) is a neuropeptide which is reported to be a potential endogenous anti-inflammatory factor in several conditions. To testify the potential involvement of CST in airway inflammatory reaction, an ovalbumin (OVA)-induced mice model was established in wild-type (WT) as well as CST-knockout (<em>Cort</em><sup>-/-</sup>) mice. Thereafter, lung tissue or cell samples were gathered in each group, and histological analysis as well as cell counting assay indicated that <em>Cort</em><sup>-/-</sup> mice exhibited exaggeration of asthma compared with WT control group. Moreover, mRNA sequencing assay revealed that CCL2 was a potential target of CST in asthma, and administration of CCL2 inhibitor alleviated airway inflammation of asthma in <em>Cort</em><sup>-/-</sup> mice. Moreover, NF-κB signaling pathway might be closely associated with the protective function of CST in asthma, as enhanced activation of NF-κB signaling pathway was observed in OVA-induced asthma model of <em>Cort</em><sup>-/-</sup> mice, and SN50, an inhibitor of NF-κB signaling pathway, antagonized asthma development in <em>Cort</em><sup>-/-</sup> mice. In summary, CST might represent as a promising target for the treatment of asthma through interacting with CCL2 and NF-κB signaling pathway.</p>
biochemistry & molecular biology,biophysics
What problem does this paper attempt to address?